300247 Stock Overview
Engages in the manufacture, export, and sale of sauna products in China. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Youngy Health Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥3.82 |
52 Week High | CN¥4.88 |
52 Week Low | CN¥2.24 |
Beta | 0.42 |
11 Month Change | 15.41% |
3 Month Change | 57.20% |
1 Year Change | 2.41% |
33 Year Change | 12.68% |
5 Year Change | 43.07% |
Change since IPO | -53.47% |
Recent News & Updates
Recent updates
Shareholder Returns
300247 | CN Leisure | CN Market | |
---|---|---|---|
7D | -4.7% | -1.4% | -2.1% |
1Y | 2.4% | -2.2% | 2.8% |
Return vs Industry: 300247 exceeded the CN Leisure industry which returned -2.3% over the past year.
Return vs Market: 300247 underperformed the CN Market which returned 5.4% over the past year.
Price Volatility
300247 volatility | |
---|---|
300247 Average Weekly Movement | 11.1% |
Leisure Industry Average Movement | 7.5% |
Market Average Movement | 8.3% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 300247's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300247's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | 421 | Xiao Dong Qian | www.lekingwellness.net |
Youngy Health Co., Ltd. engages in the manufacture, export, and sale of sauna products in China. Its products include infrared sauna, traditional sauna, and foot sauna; and portable steam and infrared sauna products, as well as air purifiers. The company also offers carbon heating painting products, functional sofas and chairs, saunalux, and SUP and boat products.
Youngy Health Co., Ltd. Fundamentals Summary
300247 fundamental statistics | |
---|---|
Market cap | CN¥3.07b |
Earnings (TTM) | CN¥37.33m |
Revenue (TTM) | CN¥631.08m |
82.3x
P/E Ratio4.9x
P/S RatioIs 300247 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300247 income statement (TTM) | |
---|---|
Revenue | CN¥631.08m |
Cost of Revenue | CN¥438.62m |
Gross Profit | CN¥192.46m |
Other Expenses | CN¥155.13m |
Earnings | CN¥37.33m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.046 |
Gross Margin | 30.50% |
Net Profit Margin | 5.92% |
Debt/Equity Ratio | 0% |
How did 300247 perform over the long term?
See historical performance and comparison